Envista (NYSE:NVST) Hits New 12-Month High – Here’s What Happened

Envista Holdings Corporation (NYSE:NVST) shares reached a new 52-week high on Wednesday . The company traded as high as $24.25 and last traded at $24.22, with a volume of 2140295 shares traded. The stock had previously closed at $23.23.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on NVST shares. Stifel Nicolaus set a $25.00 target price on shares of Envista in a research note on Thursday, October 30th. JPMorgan Chase & Co. lifted their price objective on Envista from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Tuesday, December 16th. Robert W. Baird set a $27.00 price objective on Envista in a research note on Friday, October 31st. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. Finally, Wall Street Zen upgraded Envista from a “buy” rating to a “strong-buy” rating in a report on Saturday. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $21.77.

Envista Price Performance

The stock has a 50-day simple moving average of $21.19 and a 200 day simple moving average of $20.69. The company has a market cap of $3.98 billion, a PE ratio of 268.85, a P/E/G ratio of 1.04 and a beta of 0.99. The company has a quick ratio of 2.02, a current ratio of 2.37 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Envista had a return on equity of 5.90% and a net margin of 0.58%.The firm had revenue of $669.90 million during the quarter, compared to the consensus estimate of $639.49 million. During the same period last year, the company earned $0.12 EPS. The company’s quarterly revenue was up 11.5% on a year-over-year basis. Equities analysts expect that Envista Holdings Corporation will post 1 EPS for the current year.

Institutional Trading of Envista

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Farther Finance Advisors LLC boosted its position in shares of Envista by 317.6% during the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after buying an additional 1,026 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after acquiring an additional 949 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in Envista by 378.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock valued at $47,000 after acquiring an additional 1,909 shares in the last quarter. Finally, SJS Investment Consulting Inc. lifted its position in shares of Envista by 10,356.5% during the third quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company’s stock worth $49,000 after purchasing an additional 2,382 shares in the last quarter.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.